AVALO THERAPEUTICS INC (AVTX)
US05338F3064 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 110.18M | 7.42M | 13.17M | 54.59M | 18.92M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 35.00K | 136.00K | 1.92M | 4.80M | 4.39M | |||
| Inventories | N/A | 0.00 | 20.00K | 40.00K | 0.00 | |||
| Other Current Assets | 1.00M | 844.00K | 1.31M | 2.42M | 2.70M | |||
| Total Current Assets | 111.21M | 8.39M | 16.42M | 61.85M | 26.01M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.88M | 1.97M | 2.41M | 2.70M | 1.61M | |||
| Goodwill | 10.50M | 10.50M | 14.41M | 14.41M | 14.41M | |||
| Intangibles | N/A | N/A | 0.00 | 40.00K | 1.59M | |||
| Other Non-Current Assets | 131.00K | 131.00K | 130.00K | 1.23M | 150.00K | |||
| Total Non-Current Assets | 12.52M | 12.60M | 16.95M | 18.36M | 17.75M | |||
| TOTAL ASSETS | 123.73M | 20.99M | 33.37M | 80.21M | 43.76M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 5.93M | N/A | N/A | |||
| Accrued Expenses | 7.38M | 4.17M | 12.71M | 16.14M | 11.31M | |||
| Accounts Payable | 916.00K | 446.00K | 2.88M | 3.37M | 2.57M | |||
| Other Current Liabilities | 207.40M | 0.00 | 600.00K | 380.00K | 1.34M | |||
| Total Current Liabilities | 215.70M | 4.62M | 22.11M | 19.89M | 15.22M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 13.49M | 32.83M | 0.00 | |||
| Deferred Taxes/Income | 162.00K | 155.00K | 140.00K | 110.00K | 90.00K | |||
| Other Non-Current Liabilities | 8.95M | 8.92M | 8.54M | 4.30M | 3.88M | |||
| Total Non-Current Liabilities | 9.11M | 9.07M | 22.17M | 37.24M | 3.97M | |||
| TOTAL LIABILITIES | 224.81M | 13.69M | 44.28M | 57.13M | 19.19M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -456.42M | -335.13M | -303.82M | -262.17M | -177.79M | |||
| Additional Paid In Capital | 343.88M | 342.44M | 292.90M | 285.14M | 202.28M | |||
| Common Shares | 11.46M | 1.00K | 10.00K | 110.00K | 80.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 1.03M | 801.75K | 9.43M | 9.40M | 6.25M | |||
| Tangible Book Value per Share | -118.98 | -3.99 | -2.69 | 0.92 | 1.37 | |||
| Total Shareholders' Equity | -101.08M | 7.30M | -10.92M | 23.08M | 24.56M | |||
| TOTAL LIABILITIES AND EQUITY | 123.73M | 20.99M | 33.37M | 80.21M | 43.76M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | -1.24 | 1.42 | N/A | |||
| Current Ratio | 0.52 | 1.82 | 0.74 | 3.11 | 1.71 | |||
| Return On Assets (ROA) | -115.48% | -150.26% | -124.84% | -105.20% | -145.11% | |||
| Return On Equity (ROE) | N/A | -431.87% | N/A | -365.60% | -258.55% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD